Last update :
28/04/2024
References   References 2348  
Type : Manufacturer

Research teams :
Authors :
Title : Eculizumab (Soliris®) – Summary of Product Characteristics
Reference : Alexion Europe SAS 2007

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionEculizumab Various
Stability in solutions Not specified NaCl 0,9% or Glucose 5% 5 mg/ml 2-8°C Not specified
24 Hour
Stability in solutions Not specified Sodium chloride 0,45% 5 mg/ml 2-8°C Not specified
24 Hour

  Mentions Légales